ICS + LABA combination inhaler
Beclometasone with formoterol
Brand names: Fostair
Adult dose
Dose: 100/6 or 200/6: 1–2 inhalations BD; MART regimen 1 BD + PRN
Route: Inhaled (pMDI)
Frequency: BD ± PRN
Clinical pearls
- NICE NG80 / GINA / BTS-SIGN: ICS-formoterol MART preferred for adults & adolescents
- Extra-fine particle formulation (Fostair) — differential lung deposition vs other ICS-LABA
Contraindications
- Untreated asthma exacerbation
- Hypersensitivity
Side effects
- Tremor
- Tachycardia
- Oral candidiasis
- Hypokalaemia
- Pneumonia (COPD)
- Adrenal suppression (high-dose)
Interactions
- Beta-blockers
- QT-prolonging drugs
- CYP3A4 inhibitors
- Diuretics
Monitoring
- Asthma control
- PEFR
- Inhaler technique
Reference: BNF; NICE NG80; BTS/SIGN; GINA; https://bnf.nice.org.uk/drugs/beclometasone-with-formoterol/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024